Search
for
Sort by
Research 481–510 of 1000+
- 44182 Treatment with Oral Janus Kinase Inhibitors in Adults Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Drug Armamentarium for alopecia areata
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology)
- Baricitinib in Dermatology: Expanding Therapeutic Horizons Beyond Alopecia Areata
- Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study
- Baricitinib-loaded EVs promote alopecia areata mouse hair regrowth by reducing JAK-STAT-mediated inflammation and promoting hair follicle regeneration
- Baricitinib (Olumiant)
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System
- JAK UZYSKAĆ PRAWO PRACY JAKO LEKARZ W POLSCE, KWESTIA EGZAMINU JĘZYKOWEGO. PARADOKS POMIĘDZY BRAKAMI W ZAWODACH MEDYCZNYCH, A DOSTĘPEM DO ZAWODU LEKARZA W POLSCE DLA LEKARZY, KTÓRZY NIE STUDIOWALI W POLSCE
- 026 Targeting pathogenic MICA-NKG2D interactions by statins: A novel adjunct treatment strategy for alopecia areata management?
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- Acne exacerbation after tofacitinib treatment for alopecia areata